Showing results (121-130 of 132) with videos related to

Sort By:
Pageof 14
Frontiers in Immunology|April 17, 2024
Autoimmunity in thymic epithelial tumors: a not yet clarified pathologic paradigm associated with several unmet clinical needsMatteo Perrino, Emanuele Voulaz, Simone Balin, et al.
JCI Insight|November 6, 2019
NKp46-expressing human gut-resident intraepithelial Vδ1 T cell subpopulation exhibits high antitumor activity against colorectal cancerJoanna Mikulak, Ferdinando Oriolo, Elena Bruni, et al.
Blood Advances|August 20, 2020
Impact of donor age and kinship on clinical outcomes after T-cell-replete haploidentical transplantation with PT-CyJacopo Mariotti, Anna Maria Raiola, Andrea Evangelista, et al.
Blood Advances|November 26, 2019
CD56 as a marker of an ILC1-like population with NK cell properties that is functionally impaired in AMLBérengère Salomé, Alejandra Gomez-Cadena, Romain Loyon, et al.
Bone Marrow Transplantation|September 3, 2022
Impact of second-degree related donor on the outcomes of T cell-replete haploidentical transplantation with post-transplant cyclophosphamideJacopo Mariotti, Anna Maria Raiola, Andrea Evangelista, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 2019
CXCR3 Identifies Human Naive CD8<sup>+</sup> T Cells with Enhanced Effector Differentiation PotentialGabriele De Simone, Emilia M C Mazza, Antonino Cassotta, et al.
Journal of Autoimmunity|September 25, 2019
The challenges of primary biliary cholangitis: What is new and what needs to be doneBenedetta Terziroli Beretta-Piccoli, Giorgina Mieli-Vergani, Diego Vergani, et al.
Nature Immunology|October 13, 2020
Two subsets of stem-like CD8<sup>+</sup> memory T cell progenitors with distinct fate commitments in humansGiovanni Galletti, Gabriele De Simone, Emilia M C Mazza, et al.
Nature Communications|September 21, 2017
Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axisSara Trabanelli, Mathieu F Chevalier, Amaia Martinez-Usatorre, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2025
Characterization and Clinical Implications of p53 Dysfunction in Patients With Myelodysplastic SyndromesMatteo Zampini, Elena Riva, Luca Lanino, et al.
Pageof 14